C147H174Cl4N24O18 — CID 157340066
N-[5-(4-acetylpiperazin-1-yl)-7-chloro-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide;N-[6,7-bis(2-methoxyethoxy)-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide;N-[7-chloro-5-(1-ethylpiperidin-4-yl)oxy-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]benzamide;N-[7-chloro-6-(1-ethylpiperidin-4-yl)oxy-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]benzamide;N-[7-chloro-5-(2-oxopropyl)-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide (PubChem CID 157340066) has the molecular formula C147H174Cl4N24O18 and a molecular weight of 2706.97 g/mol. Its IUPAC name is N-[5-(4-acetylpiperazin-1-yl)-7-chloro-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide;N-[6,7-bis(2-methoxyethoxy)-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide;N-[7-chloro-5-(1-ethylpiperidin-4-yl)oxy-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]benzamide;N-[7-chloro-6-(1-ethylpiperidin-4-yl)oxy-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]benzamide;N-[7-chloro-5-(2-oxopropyl)-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide.
| Compound Name | N-[5-(4-acetylpiperazin-1-yl)-7-chloro-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide;N-[6,7-bis(2-methoxyethoxy)-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide;N-[7-chloro-5-(1-ethylpiperidin-4-yl)oxy-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]benzamide;N-[7-chloro-6-(1-ethylpiperidin-4-yl)oxy-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]benzamide;N-[7-chloro-5-(2-oxopropyl)-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide |
|---|---|
| PubChem CID | 157340066 |
| Molecular Formula | C147H174Cl4N24O18 |
| Molecular Weight | 2706.97 g/mol |
| Exact Mass | 2703.22 |
| IUPAC Name | N-[5-(4-acetylpiperazin-1-yl)-7-chloro-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide;N-[6,7-bis(2-methoxyethoxy)-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide;N-[7-chloro-5-(1-ethylpiperidin-4-yl)oxy-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]benzamide;N-[7-chloro-6-(1-ethylpiperidin-4-yl)oxy-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]benzamide;N-[7-chloro-5-(2-oxopropyl)-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-methylbenzamide |
| SMILES | C=CC(=O)N1CCCCC(n2c(NC(=O)c3cccc(C)c3)nc3cc(CC(C)=O)cc(Cl)c32)C1.C=CC(=O)N1CCCCC(n2c(NC(=O)c3cccc(C)c3)nc3cc(N4CCN(C(C)=O)CC4)cc(Cl)c32)C1.C=CC(=O)N1CCCCC(n2c(NC(=O)c3cccc(C)c3)nc3ccc(OCCOC)c(OCCOC)c32)C1.C=CC(=O)N1CCCCC(n2c(NC(=O)c3ccccc3)nc3cc(OC4CCN(CC)CC4)cc(Cl)c32)C1.C=CC(=O)N1CCCCC(n2c(NC(=O)c3ccccc3)nc3ccc(OC4CCN(CC)CC4)c(Cl)c32)C1 |
| InChI | InChI=1S/C30H35ClN6O3.2C30H36ClN5O3.C30H38N4O6.C27H29ClN4O3/c1-4-27(39)36-11-6-5-10-23(19-36)37-28-25(31)17-24(35-14-12-34(13-15-35)21(3)38)18-26(28)32-30(37)33-29(40)22-9-7-8-20(2)16-22;1-3-27(37)35-15-9-8-12-22(20-35)36-28-25(31)18-24(39-23-13-16-34(4-2)17-14-23)19-26(28)32-30(36)33-29(38)21-10-6-5-7-11-21;1-3-26(37)35-17-9-8-12-22(20-35)36-28-24(32-30(36)33-29(38)21-10-6-5-7-11-21)13-14-25(27(28)31)39-23-15-18-34(4-2)19-16-23;1-5-26(35)33-14-7-6-11-23(20-33)34-27-24(31-30(34)32-29(36)22-10-8-9-21(2)19-22)12-13-25(39-17-15-37-3)28(27)40-18-16-38-4;1-4-24(34)31-11-6-5-10-21(16-31)32-25-22(28)14-19(13-18(3)33)15-23(25)29-27(32)30-26(35)20-9-7-8-17(2)12-20/h4,7-9,16-18,23H,1,5-6,10-15,19H2,2-3H3,(H,32,33,40);3,5-7,10-11,18-19,22-23H,1,4,8-9,12-17,20H2,2H3,(H,32,33,38);3,5-7,10-11,13-14,22-23H,1,4,8-9,12,15-20H2,2H3,(H,32,33,38);5,8-10,12-13,19,23H,1,6-7,11,14-18,20H2,2-4H3,(H,31,32,36);4,7-9,12,14-15,21H,1,5-6,10-11,13,16H2,2-3H3,(H,29,30,35) |
| InChIKey | BGHHNJOYTZGAOB-UHFFFAOYSA-N |
| XLogP | 25.26 |
| TPSA | 438.63 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 193 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2706.97 |
| LogP ≤ 5 | 25.26 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 31 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|